Targeted Nanotechnology from Bench to Bedside.

Targeted Nanotechnology from Bench to Bedside. Curr Cancer Drug Targets. 2019;19(1):3-4 Authors: Sapalidis K, Kosmidis C, Laskou S, Katsaounis A, Mantalobas S, Passos I, Michalopoulos N, Amaniti A, Sardeli C, Zarogoulidis P Abstract PMID: 30672409 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30672409?dopt=Abstract

Source: Current Cancer Drug Targets - January 25, 2019 Category: Cancer & Oncology Authors: Sapalidis K, Kosmidis C, Laskou S, Katsaounis A, Mantalobas S, Passos I, Michalopoulos N, Amaniti A, Sardeli C, Zarogoulidis P Tags: Curr Cancer Drug Targets Source Type: research

More News: Cancer | Cancer & Oncology | Nanotechnology | Science